H2020Индивидуална стипендия2021–2024

MONOCLE · Emission Control of Rare-Earth Nanoparticles

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2021-04-01 → 2024-03-31
Финансиране от ЕС
245 732 €
Участници
2
Схема
MSCA-IF

Линиите свързват координатора с партньорите.

Накратко на български

Наночастици с редки земни елементи се изследват за способността им да превръщат инфрачервената светлина във видими цветове. Това помага за по-точно откриване на болести, доставка на лекарства и измерване на температурата в клетките.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Emission Control of Rare-Earth Nanoparticles

Project MONOCLE (Logo 1) explores the optical properties of rare-earth doped nanoparticles (RENPs) envisioned to be used in various biomedical and technological applications. RENPs have a unique ability to convert invisible near-infrared light to visible colors via a process of upconversion. Such upconverting RENPs are researched for disease detection, drug delivery, and cell-level temperature sensing and are used as super-resolution optical probes. Successful implementation of these practices, though, depends on our ability to generate upconversion emissions effectively and controllably. It is challenging to maximize upconversion properties of RENPs because of a large number of variables that influence the final performance of RENPs. Compositionally, a vast space of explorable parameters is determined by the choice of nanocrystal host and rare-earth dopants, their concentrations, and placement within the nanocrystal (so-called core/shell engineering). Furthermore, the photoluminescence of RENPs is affected by the wavelength, power, and temporal modulations (pulsing) of laser excitation that, in turn, can serve as a means to control RENP emission deliberately. Thus, to effectively cover these parameter spaces and create application-targeted RENPs in a timely fashion, high-throughput numerical and experimental approaches have to be combined with the rational design of RENPs. This project aims to explore different RENP architectures, including highly nonlinear photon avalanching nanoparticles (ANPs) and their excitation pathways to aid in creating a set of specialized nanotools for future biomedical and technological applications. To reach different milestones of the project, numerical simulations, high-throughout robotic synthesis, and complete optical characterization are combined to create and investigate state-of-the-art RENPs. In turn, these approaches and guiding principles were successfully applied in the course of project MONOCLE, yielding 1) the synthesis method for a new class of host material for RENPs, 2) the development of a generalized approach to tune the color of photon avalanches and imprint photon avalanches on virtually any linear emitter, and 3) the discovery of an extremely nonlinear photoactivation dynamic that transforms ANPs into bistable ANPs - having two distinct steady-state responses under identical excitation conditions, contingent on the history of excitation intensity. These research accomplishments have been successfully published in the highest-impact chemical and physical journals and presented at international conferences, thus garnering interest and acclaim from the scientific community. The disseminated results are expected to impact and advance the fields of super-resolution imaging, sensing, and general-purpose optical data handling. Furthermore, this project had a valuable impact on the career development of the beneficiary, aiding in strengthening existing collaborations, forging new ones, and allowing to establish the beneficiary as an independent and goal-oriented researcher.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Optical theranostic (diagnostic + therapy) techniques are low-cost, safe, and constitute a next big leap in the betterment of human healthcare. In that regard, luminescent nanoparticles (NPs) are poised to become the multifunctional instruments of personalized medicine. However, present-day theranostic NPs provide no control over their arsenal of capabilities – their competences are often entangled so that diagnostics cannot be done without therapy. In the same way that surgeons do not cut before ascertaining what and where to cut, so do light-responsive nanoparticles must have the flexibility to switch between their imaging/sensing and therapeutic modalities at-will. Rare-earth NPs (RENPs) are endowed with downshifting (Stokes) and upconversion (anti-Stokes) luminescence stimulated by near-infrared light; thus, RENPs are designed for non-invasive deep-tissue optical imaging (to diagnose) and in-situ mediation of photochemical processes (to treat). As such, RENPs are just the right candidates to decouple therapy from diagnostics, while preserving both in a single theranostic NP. With MONOCLE, I propose a tangible and timely development of RENPs with built-in control over their different emission modes. Capitalizing on the modular design of RENPs in unison with temporally modulated laser excitation, I intend to separate downshifting and upconversion processes creating truly-multifunctional theranostic RENPs (TMTs). In essence, TMTs are destined to apply “measure twice and cut once” philosophy – which constitutes benign examination and diagnosis of the target, with in-situ treatment available on-demand. Successful development of TMTs is projected to have far-reaching implications in safe and selective use of light-controlled nanomedicines. Furthermore, the multidisciplinary nature of this project is anticipated to foster new RENP architectures and alternative excitation pathways, decisively advancing not only biomedical but also luminescent materials science research.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз